Literature DB >> 11751671

Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis.

H Douglas1, K Michaelides, D A Gorog, E Durante-Mangoni, N Ahmed, G J Davies, E G D Tuddenham.   

Abstract

OBJECTIVE: To explore the potential of the GPIbalpha gene variable number tandem repeat (VNTR) and -5T/C Kozak polymorphisms to act as independent risk factors for myocardial infarction.
METHODS: 256 patients aged 33-80 years (180 caucasian, 76 Indian Asian) were recruited at cardiac catheterisation for any diagnostic indication, and divided into two groups: group A, with confirmed previous myocardial infarction evident on ECG or ventriculogram (88 patients, 79 men, 9 women) and group B, with no evidence of myocardial infarction (168 patients, 101 men, 67 women).
RESULTS: There was no significant difference in race, age, hypertension, smoking status, or family history between the infarct and non-infarct groups, though there was a significant difference in sex (89.8% male in group A, 60.1% male in group B, p < 0.001). Genotype analysis showed a strong association between the GPIbalpha Kozak homozygous TT genotype and the occurrence of myocardial infarction (group A: TT 85.2%, TC 12.5%, CC 2.3%; group B: TT 67.3%, TC 32.7%, p = 0.001). No significant association was found between myocardial infarction and the GPIbalpha VNTR, although analysis of the CC VNTR genotype against all other GPIbalpha VNTR genotypes showed a marginal association with myocardial infarction (p = 0.059). There was no association between the Kozak sequence polymorphism (p = 0.797) or GPIbalpha VNTR (p = 0.714) and the degree of vessel disease.
CONCLUSIONS: The homozygous TT Kozak genotype may be a significant factor in the outcome of coronary artery disease completed by myocardial infarction. Conversely, the Kozak C allele in the heterozygous state TC may confer some protection against myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751671      PMCID: PMC1766969          DOI: 10.1136/heart.87.1.70

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  30 in total

1.  Evidence for involvement of trans-acting factors in selection of the AUG start codon during eukaryotic translational initiation.

Authors:  S McBratney; P Sarnow
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

2.  The largest isoform of platelet membrane glycoprotein Ib alpha is commonly distributed in eastern Asian populations.

Authors:  F Ishida; K Furihata; K Ishida; H Kodaira; K S Han; D Z Liu; K Kitano; K Kiyosawa
Journal:  Thromb Haemost       Date:  1996-08       Impact factor: 5.249

Review 3.  Platelets and shear stress.

Authors:  M H Kroll; J D Hellums; L V McIntire; A I Schafer; J L Moake
Journal:  Blood       Date:  1996-09-01       Impact factor: 22.113

Review 4.  The molecular mechanism of platelet adhesion.

Authors:  M C Berndt; C M Ward; M De Luca; D A Facey; P A Castaldi; S J Harris; R K Andrews
Journal:  Aust N Z J Med       Date:  1995-12

5.  Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation.

Authors:  M Murata; Y Matsubara; K Kawano; T Zama; N Aoki; H Yoshino; G Watanabe; K Ishikawa; Y Ikeda
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

6.  Systematic screening for genetic polymorphism in human platelet glycoprotein Ibalpha.

Authors:  S Kaski; R Kekomäki; J Partanen
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

7.  Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.

Authors:  B Savage; E Saldívar; Z M Ruggeri
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

8.  Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease.

Authors:  R Gonzalez-Conejero; M L Lozano; J Rivera; J Corral; J A Iniesta; J M Moraleda; V Vicente
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

9.  The largest variant of platelet glycoprotein Ib alpha has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine145.

Authors:  F Ishida; K Furihata; K Ishida; J Yan; K Kitano; K Kiyosawa; S Furuta
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

10.  Association of a variable number of tandem repeats (VNTR) in glycoprotein Ib alpha and HPA-2 alloantigens.

Authors:  S Simsek; P M Bleeker; C E van der Schoot; A E von dem Borne
Journal:  Thromb Haemost       Date:  1994-11       Impact factor: 5.249

View more
  11 in total

Review 1.  Role of platelet glycoprotein polymorphisms in cardiovascular diseases.

Authors:  Christian Meisel; José A López; Karl Stangl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-12       Impact factor: 3.000

2.  Detection of functional differences between different platelet membrane glycoprotein Ibalpha variable number tandem repeat and Kozak genotypes as shown by the PFA-100 system.

Authors:  H Douglas; G J Davies; K Michaelides; D A Gorog; H Timlin; N Ahmed; E G D Tuddenham
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

Review 3.  The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors:  Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-07-14       Impact factor: 4.481

Review 4.  Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.

Authors:  Marlene S Williams; Ethan J Weiss; Marc S Sabatine; Daniel I Simon; Wadie F Bahou; Lewis C Becker; Leslie V Parise; Harold L Dauerman; Patricia A French; Susan S Smyth; Richard C Becker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12       Impact factor: 8.311

5.  Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy.

Authors:  Paul F Bray; Timothy D Howard; Eric Vittinghoff; David C Sane; David M Herrington
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

6.  Platelet receptor gain-of-function single nucleotide polymorphisms in carotid and vertebral stenosis patients.

Authors:  Andrea Kopp Lugli; Martin M Brown; Jan Steffel; Linda Büchi; Dorothee Förnzler; Annabelle Dupont; Pascale Gaussem; Marc Forestier; Juerg H Beer
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

7.  Association between polymorphisms of platelet membrane glycoprotein Ibα and risk of coronary heart disease in Han Chinese, Henan, China.

Authors:  Jinghua Zhang; Liang Zhao; Peisheng Lv; Guizhi Liu; Weiguo Du; Fan Yang; Youyou Du; Luosha Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

8.  Platelet GPIbalpha, GPIV and vWF polymorphisms and fatal pre-hospital MI among middle-aged men.

Authors:  Minna Pellikka; Lassi Narhi; Markus Perola; Antti Penttila; Pekka J Karhunen; Jussi Mikkelsson
Journal:  J Thromb Thrombolysis       Date:  2007-07-11       Impact factor: 2.300

9.  Association of Platelet Membrane Glycoprotein HPA-2a/b, GP VI T13254C, and GP Ibα VNTR Polymorphisms with Risk of Coronary Artery Disease: A Meta-Analysis.

Authors:  Wei Ni; Jidong He; Haoyu Wang; Tao Liu
Journal:  Biomed Res Int       Date:  2017-05-18       Impact factor: 3.411

10.  Platelet glycoproteins and fibrinogen in recovery from idiopathic sudden hearing loss.

Authors:  Daniel Weiss; Bruno Neuner; Kerstin Gorzelniak; Alexis Bremer; Claudia Rudack; Michael Walter
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.